Upload
hirzi-nugraha
View
11
Download
1
Tags:
Embed Size (px)
DESCRIPTION
fesarq
Citation preview
ANTIBIOTIKA
Aryan MoritaBiomedika KG
DEFINITION
• Low molecular weight microbial metabolites which can kill or inhibit the growth of susceptible bacteria.
• Synthetic antimicrobial agents which may or may not be derived from microbial metabolites
HISTORY
HISTORY
ANTIMICROBIAL AGENTS DERIVED FROM MICROORGANISMS
Microorganism Antimicrobial agent
Bacillus colistinus Colistin (polymyxin E)
B.subtilis Bacitracin
Penicillium notatum Penicillin G
Streptomyces sp Spectinomycin, Tetracylines
S.erythreus Erythromycin
S.griseus Streptomycin
CLASSIFICATION
BACTERICIDAL
•Cause irreparable damage and bacterial cell death•Binding irreversibly to target structure
BACTERIOSTATIC
•Inhibit growth of bacteria•Allowing host immune defenses to eliminate infection
SPECTRUM
Narrow Broad
MODE AND SITE OF ACTION
INHIBITION OF CELL WALL SYHTHESIS
• Prevent cross-linking of peptdoglycan chain• Penicillin & cephalosporine β lactam ring• Mode of action: involves binding to cell
receptors (PBPs) inhibition of transpeptidation reaction inactivation of an inhibitor of autolytic enzym in the cell wall
INHIBITION OF CELL MEMBRANE FUNCTION
• Cell membrane disrupted macromolecules and ion escape from the cell cell damage and death
INHIBITION OF PROTEIN SYNTHESIS
• Attachment to a spesific receptor blocks normal activity of initiation complex of peptide formation mRNA missread break up polysome to monosome incapable to synthesis protein
INHIBITION OF NUCLEIC ACID SYNTHESIS
• Disruption of DNA structure• Inhibition of DNA dependent RNA polymerase• Interface with DNA gyrase• Interface with DNA synthesis by blocking folic
acid production
RESISTANCE TO ANTIMICROBIAL DRUGS
Mo produce enzym that destroy active drug
Mo change their permeability to the drug
Mo develop an altered stuctural target for the drugs
Mo develop an altered metabolic pathway
Mo develop an altered enzyme that can still perform metabolic function
ANTIMICROBIAL ACTIVITY IN VITRO
Potency of an antibacterial agent in solution
Concentration in body fluids or tissue
Susceptibility of a given mo to known concentrations of the drugs
FACTORS AFFECTING ANTIMICROBIAL ACTIVITY
pH Component of medium
Stability of drug
Size of inoculum
Length of incubation
Metabolic activity of mo
Chemical Structure
• Sulfonamides and related drugs• Diaminopyrimidines trimetropin• Quinolone ciprofloxacin, norfloxacin, etc• Beta lactam penicilin, cephalosphorine• Tetracycline minocycline, doxycycline, etc
19/04/2023 Aryan Morita
Con’t
• Nitrobenzene derivates chloramphenicol• Aminoglycosides stepromycine,
gentamycin,etc• Macrolide erythromycine, dll• Polypeptide antibiotics polymyxin,
bacitracin, dll• Glycopeptides vancomycine
19/04/2023 Aryan Morita
Con’t
• Oxazolidinone linezoid• Nitrofuran derivates furazolidone• Nitroimidazole metronidazole• Nicotinic acid derivates isoniasid• Polyene antibiotics nystatine• Azole derivates miconazole• Others rifampin
19/04/2023 Aryan Morita
Kriteria Penggunaan antibiotik
• Tepat indikasi• Tepat penderita• Tepat obat• Tepat dosis, rute, waktu, dan lama pemberian• Waspada efek samping
19/04/2023 Aryan Morita
Penggunaan yg tidak tepat• Viruses• Dosis yg tidak tepat• Informasi yg Inadequate• Tidak dilakukannya drainase ketika operasi
19/04/2023 Aryan Morita
Seleksi antimikroorganisme• Identifikasi MO• Menggunakan obat yg sensitif thd MO• Pertimbangkan host factors – tempat tjdnya infeksi– Sistem pertahanan inang– allergies, – Ketidakmampuan dari drug of choice untuk menembus
tempat infeksi– Kerentanan pasien thd tjdnya toksisitas
19/04/2023 Aryan Morita
ANTIMICROBIAL COMBINATION
• To give prompt treatment in desperately ill patients suspected serious microbial infection
• To delay the emergence of microbial mutants resistant
• To treat mixed infection• To achieve bactericidal synergism or to
provide bacterial action
MECHANISM
synergism antagonism
THANK YOU...SAYONARA